Slaoui informed Bancel that Moderna had not recruited enough minority candidates into its vaccine trials. Sky-high infection rates accelerated the pace of clinical trials, the most time-consuming part of the process. The government was ready to foot much of the development bill, guide the clinical trials and even deliver supplies to factories. Senior leaders convened weekly check-ins with companies’ clinical trial heads, tracking recruitment of trial participants and covering whiteboards with potential distribution plans. Last Sunday, expecting the results from Moderna's trial, Bancel closeted himself in a home office in his Boston townhouse.

Source: bd News24 November 22, 2020 07:30 UTC